UPM brings its first clinical product to market

Made from nanofibrillar cellulose origined in Finnish birch trees, FibDex wound dressing is supposed to be UPM Biomedicals’ door opener to the medical device market. It’s the first clinical product of the company UPM and shows promising signs for future developments, such as cell therapy. The product was developed in collaboration…

Continue reading